PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

In vitro studies assess the optimal concentration of propolis as a radioprotector

2012-07-07
(Press-News.org) A team of researchers from the Technical University of Valencia, the University Hospital La Fe, the University of Valencia and the Universitat Autònoma de Barcelona conducted in vitro studies of cytotoxicity (cellular affection) to assess the optimal concentration level of propolis in which this natural substance extracted from bee resin would offer the maximum protection against ionised radiation and not be toxic for blood cells.

According to the results of the research, this optimal concentration level is between 120-500 micrograms/mL. "Within this range can be found maximum protection against radiation-induced damage and the substance does not reveal neither a cytotoxicity nor a genotoxicity effect on non-irradiated human lymphocytes", says Alegria Montoro, head of the Laboratory of Biological Dosimetry at the University Hospital La Fe and lecturer of the Master in Radiological Protection in Radioactive and Nuclear Facilities offered by the UPV.

The conclusions of this study, which receives funding from the Spanish Nuclear Security Council (CSN), represent a starting point for future clinical applications using propolis. The results were published in the journal Food and Chemical Toxicology; in August a full revision of the study will be presented at the Annual International Conference of the IEEE Engineering in Medicine and Biology Society EMBC12, which will be held in San Diego, California.

In the study, the team of researchers used four genetic biomarkers, including the mytotic index and the cell proliferation kinetics, with the aim of determining whether propolis has cytotoxic effects on cells. "Using these biomarkers makes it possible to discover how a substance affects cell division: a substance which is cytotoxic and modifies the cell division stage would do so by accelerating, slowing down or even stopping the process, and all three effects are negative", explains Alegria Montoro.

The other two biomarkers used are the study of the possible induction of chromosome alterations in non-irradiated cultures at different concentration levels and sister chromatid exchanges (SCEs), a genetic biomarker of exposure to chemical agents.

"With this study we already know the in vitro experimental level, the concentration of propolis to be used to make it act as a radiation protector agent, without being cyto/genotoxic for normal cells. This is the first step, a starting point for future clinical assays. The final objective is to develop capsules containing the adequate dosis of propolis, but many more hours of research are needed before we are able to do this", Alegria Montoro adds.

UAB lecturer Francesc Barquinero, currently on leave to work at the Institut de Radioprotection et de Sûreté Nucléaire (IRSN) headquarters in Fontenay aux Roses, France, participated in the original planning of the study and its design, as well as the interpretation of the results and posterior contextualisation of other studies published.

Antecedents

In 2008, researchers at the Institute for Industrial, Radiophysical and Environmental Safety (ISIRyM) of the Technical University of Valencia and the University Hospital La Fe demonstrated that propolis can reduce by half the damage inflicted on chromosomes by ionised radiations, thus protecting the DNA from these effects. The new study is fundamental in discovering the range of concentrations in which this substance can have a toxic effect on non-irradiated cells.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Spaceflight may extend the lifespan of microscopic worm

2012-07-07
The effect of spaceflight on a microscopic worm — Caenorhabditis elegans (C. elegans) — could help it to live longer. The discovery was made by an international group of scientists studying the loss of bone and muscle mass experienced by astronauts after extended flights in space. The results of this research have been published today, July 5 2012, in the online journal Scientific Reports. Dr Nathaniel Szewczyk, from The University of Nottingham, was part of the ICE-FIRST project which involved scientists from Japan, France, the US, and Canada. They discovered that ...

Taking tissue regeneration beyond the state-of-the-art

2012-07-07
The University of Nottingham has begun the search for a new class of injectable materials that will stimulate stem cells to regenerate damaged tissue in degenerative and age related disorders of the bone, muscle and heart. The work, which is currently at the experimental stage, could lead to treatments for diseases that currently have no cure. The aim is to produce radical new treatments that will reduce the need for invasive surgery, optimise recovery and reduce the risk of undesirable scar tissue. The research, which brings together expertise in The University of ...

Stanford scientists find molecule to starve lung cancer and improve ventilator recovery

2012-07-07
Bethesda, MD—A new research report published online in the FASEB Journal reveals a connection among sugar, cancer, and dependence on breathing machines--microRNA-320a. In the report, Stanford scientists show that the molecule microRNA-320a is responsible for helping control glycolysis. Glycolysis is the process of converting sugar into energy, which fuels the growth of some cancers, and contributes to the wasting of unused muscles such as the diaphragm when people are using ventilators. Identifying ways to use microRNA-320a to starve tumors and keep unused muscles strong ...

Prevention is better than cure for killer cardiovascular disease

2012-07-07
London (July 05 2012 ) -- European experts in cardiovascular medicine will today gather at a two day symposium to address the national agenda on cardiovascular disease prevention, held at Imperial College London and sponsored by leading independent academic and professional publisher SAGE. One session at the conference, chaired by Professors Joep Perk and David Wood will focus on the new 2012 Joint European Societies' Guidelines on cardiovascular disease prevention in clinical practice, which will appear in August issue (volume 19, issue 4) of the European Society of ...

When anxiety won't go away

2012-07-07
Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside. "The memory of the terrible events is not just erased." states first author, PD Dr. Andras Bilkei Gorzo, from the Institute for Molecular Psychiatry at the University of Bonn. "Those impacted learn rather via an active learning process that they no longer need to be afraid because ...

The 'appetite-suppressing' effect of proteins explained

2012-07-07
Frequently recommended in weight-loss diets, dietary proteins have proven effectiveness thanks to their appetite-suppressing effects. A team led by Gilles Mithieux, Director of Inserm's Unit 855 "Nutrition and the Brain" in Lyon, has managed to explain the biological mechanisms behind these properties. The researchers describe in detail the chain reactions triggered by digesting proteins, sending a 'satiety' message to the brain long after a meal. Their results, published on 5 July in the Cell review, will make it possible envisage improved care for obese or overweight ...

Can you hear me now? New strategy discovered to prevent hearing loss

2012-07-07
Bethesda, MD—If you're concerned about losing your hearing because of noise exposure (earbud deafness syndrome), a new discovery published online in the FASEB Journal offers some hope. That's because scientists from Germany and Canada show that the protein, AMPK, which protects cells during a lack of energy, also activates a channel protein in the cell membrane that allows potassium to leave the cell. This activity is important because this mechanism helps protect sensory cells in the inner ear from permanent damage following acoustic noise exposure. This information could ...

Scientists discover new trigger for immense North Atlantic plankton bloom

2012-07-07
On this July 4th week, U.S. beachgoers are thronging their way to seaside resorts and parks to celebrate with holiday fireworks. Across the horizon and miles out to sea toward the north, the Atlantic Ocean's own spring and summer ritual is unfolding: the blooming of countless microscopic plant plankton, or phytoplankton. In what's known as the North Atlantic Bloom, an immense number of phytoplankton burst into color, first "greening" then "whitening" the sea as one species follows another. In research results published in this week's issue of the journal Science, ...

Building global collaboration for biodiversity intelligence

2012-07-07
Copenhagen, Denmark – A landmark conference has agreed key priorities for harnessing the power of information technologies and social networks to understand better the workings of life on Earth, focussing on how biodiversity can continue to sustain human lives and livelihoods. The Global Biodiversity Informatics Conference (GBIC), gathering some 100 experts from around the world from 2-4 July, identified critical areas in which greater investment and better coordination could give society much better, innovative tools to monitor and manage biological resources. These ...

University of Rochester plays key roles in search for Higgs boson

2012-07-07
July 4, 2012, was an historic day in science with researchers at CERN (European Organization for Nuclear Research) announcing the discovery of a new particle that is "consistent with the Higgs boson." It was also an historic day for the University of Rochester. Not only was one of its faculty members an originator of the theory for the Higgs mechanism and the Higgs boson, three of its scientists worked on one of the experiments that led to the CERN discovery. Physicist Carl Hagen's 1964 article Global Conservation Laws and Massless Particles, co-written by Gerald Guralnik ...

LAST 30 PRESS RELEASES:

New research shows how to diagnose people with Alzheimer’s plus a hard-to-identify dementia type

Large craters offer clues to the origin of asteroid 16 Psyche

Researchers develop biochar-based photocatalyst that rapidly removes antibiotic pollutants from water

ACP supports AAP’s evidence‑based childhood vaccine schedule

Half of Native Hawaiian University of Hawaiʻi students experience period poverty, study reveals

American College of Cardiology to host New Orleans Community Health Fair

UMass Amherst research links early adult drinking to middle age cognitive decline

Early life stress linked to long-lasting digestive issues

A built-in warning system: How mosquitoes detect a common compound in plant-based mosquito repellent

Rice hosts first-of-its-kind workshop exploring how AI can accelerate discoveries in major neutrino experiment

Researchers combine flavor and nutritional value in Amazonian chocolate

Study identifies causes of potato dry rot in Colorado

Universal, ready-to-use immunotherapy detects and destroys endometrial cancer

New $1.9 million grant lets Montana State team deepen understanding of avian flu

Storytelling may hold key to building memory

Pharmacy team develops 3D-printed bandage to help heal chronic wounds

Cannibalism takes major bite out of young blue crabs, but the shallows offer a refuge

Groundbreaking PKU innovation can detect disease from a drop of blood

Differences in brain activity between ADHD and neurotypical adults

How do people quickly respond to scary sounds?

Coastal ocean chemistry now substantially shaped by humans

Brain computer interface enables rapid communication for two people with paralysis

Computational model measures key aging metric from routine biopsies

Geographic, racial, and sex disparities in time to treatment for early-onset colorectal cancer

Long-term trends in pediatric self-injury in high-income countries

Experimental therapy shows safety and signals of clinical benefit in ALS

Holding vs continuing GLP-1/GIP agonists before upper endoscopy

Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy

AI expert and industry-leading toxicologist Thomas Hartung hails launch of agentic AI platform, ToxIndex, as a “transformative moment” in chemical safety science

New genetic risk score better predicts diabetes, obesity and downstream complications

[Press-News.org] In vitro studies assess the optimal concentration of propolis as a radioprotector